Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2007 | 1 |
2010 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.
Mol Cancer Ther. 2010 Aug;9(8):2287-96. doi: 10.1158/1535-7163.MCT-10-0159. Epub 2010 Aug 3.
Mol Cancer Ther. 2010.
PMID: 20682647
Free PMC article.
Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG anti-tumor action.
Li J, Lindner DJ, Farver C, Borden EC, Yi T.
Li J, et al.
Cancer Chemother Pharmacol. 2007 Aug;60(3):341-9. doi: 10.1007/s00280-006-0378-3. Epub 2006 Nov 14.
Cancer Chemother Pharmacol. 2007.
PMID: 17103170
Item in Clipboard
Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.
Kundu S, Fan K, Cao M, Lindner DJ, Zhao ZJ, Borden E, Yi T.
Kundu S, et al.
J Immunol. 2010 Jun 1;184(11):6529-36. doi: 10.4049/jimmunol.0903562. Epub 2010 Apr 26.
J Immunol. 2010.
PMID: 20421638
Free PMC article.
Item in Clipboard
Cite
Cite